“In Chile, the biological situation continues to improve. Mainstream Chile has initiated procedures for a complete testing of all brood fish and with strict screening of the fish during the whole life cycle,” the company said in its third-quarter report. “All freshwater production for Atlantic salmon is completed on land and the use of antibiotics has reduced significantly.”
Revenue from Mainstream Chile in the third quarter totaled NOK 126.7 million ($22 million/€15.7 million), down 26.5 percent from NOK 172.4 million ($29.9
